The majority of CLL cells overexpress BCL-2 as a result of the BCL-2 gene hypomethylation, as well as loss of miR-15 and miR-16 at 13q14 and STAT3 transcription factor activation (21–23). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.